Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
183
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Combination Therapy of Polymyxin B and Amikacin for Community-Acquired Pseudomonas aeruginosa Pneumonia with MODS in a Previously Healthy Patient: A Case Report

Junyu Wang1 Department of Pharmacy, Qingdao Central Hospital, Qingdao, 266042, Shandong, People’s Republic of China
,
Lu Yun1 Department of Pharmacy, Qingdao Central Hospital, Qingdao, 266042, Shandong, People’s Republic of China
,
Hong Zhao1 Department of Pharmacy, Qingdao Central Hospital, Qingdao, 266042, Shandong, People’s Republic of China
&
Xiangpeng Li2 Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, People’s Republic of ChinaCorrespondence[email protected]
Pages 2895-2900 | Published online: 27 Jul 2021

References

  • Rello J, Borgatta B, Lisboa T. Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century. Intensive Care Med. 2013;39(12):2204–2206. doi:10.1007/s00134-013-3046-124146002
  • Cilloniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340–346. doi:10.1136/thx.2010.14398221257985
  • Sakamoto N, Tsuchiya K, Hikone M. Community-acquired necrotizing pneumonia with bacteremia caused by Pseudomonas aeruginosa in a patient with emphysema: an autopsy case report. Respir Investig. 2018;56:189–194.
  • Maharaj S, Isache C, Seegobin K, et al. Necrotizing Pseudomonas aeruginosa community-acquired pneumonia: a case report and review of the literature. Case Rep Infect Dis. 2017;2017:1717492. doi:10.1155/2017/1717492
  • Hatchette TF, Gupta R, Marrie TJ. Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis. 2000;31(6):1349–1356. doi:10.1086/31748611096001
  • Sakamoto N, Tsuchiya K, Hikone M. Community-acquired necrotizing pneumonia with bacteremia caused by Pseudomonas aeruginosa in a patient with emphysema: an autopsy case report. Respir Investig. 2018;56(2):189–194. doi:10.1016/j.resinv.2017.12.008
  • Riviere P, Patin D, Delaporte E, et al. Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa. IDCases. 2019;17:e00563. doi:10.1016/j.idcr.2019.e0056331193456
  • Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301. doi:10.1017/ice.2016.17427573805
  • Hauser AR, Jain M, Bar-Meir M, et al. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev. 2011;24(1):29–70.21233507
  • Takajo D, Iwaya K, Katsurada Y, et al. Community-acquired lobar pneumonia caused by Pseudomonas aeruginosa infection in Japan: a case report with histological and immunohistochemical examination. Pathol Int. 2014;64(5):224–230. doi:10.1111/pin.1216224888776
  • Xu E, Pérez-Torres D, Fragkou PC, et al. Nosocomial pneumonia in the era of multidrug-resistance: updates in diagnosis and management. Microorganisms. 2021;9(3):534. doi:10.3390/microorganisms903053433807623
  • Kalil AC, Metersky ML, Klompas M, et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):575–582. doi:10.1093/cid/ciw50427521441
  • Yoo IY, Huh K, Shim HJ, et al. Evaluation of the BioFire FilmArray pneumonia panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens. Int J Infect Dis. 2020;95:326–331. doi:10.1016/j.ijid.2020.03.02432179139
  • Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015;386(9998):1097–1108. doi:10.1016/S0140-6736(15)60733-426277247
  • Garcia-Vidal C, Fernandez-Sabe N, Carratala J, et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Repirat J. 2008;32(3):733–739. doi:10.1183/09031936.00128107
  • Sibila O, Laserna E, Maselli DJ, et al. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology. 2015;20(4):660–666. doi:10.1111/resp.1250625776134
  • Serota DP, Sexton ME, Kraft CS, et al. Severe community-acquired pneumonia due to Acinetobacter baumannii in North America: case report and review of the literature. Open Forum Infect Dis. 2018;5(3):ofy044. doi:10.1093/ofid/ofy04429564365
  • John T-J, Lalla U, Taljaard JJ, Slabbert J, Koegelenberg CFN. An outbreak of community-acquired Pseudomonas aeruginosa pneumonia in a setting of high water stress. QJM. 2017:855–856. doi:10.1093/qjmed/hcx148
  • Tsai YF, Ku YH. Necrotizing pneumonia: a rare complication of pneumonia requiring special consideration. Curr Opin Pulm Med. 2012;18(3):246–252. doi:10.1097/MCP.0b013e328352102222388585

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.